Perrigo (PRGO) → Stock, financial statements
Advertising

Perrigo: stocks, financial statements

Dividends News
Favorites

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

  • PRGO Ticker
  • 🇺🇸 NYSE Exchange
  • 10,600 Employees
3 rated

Financial statements — Perrigo

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
5.1B 4.8B 4.7B 4.9B 5.3B
Cost Of Revenue
3.2B 3.1B 2.9B 3B 3.2B
Gross Profit
1.8B 1.8B 1.8B 2B 2.1B
Research and Development
180M 190M 220M 170M 180M
Selling General and Admin
1.1B 1.1B 1B 1.1B 1.1B
Operating Expense
4.6B 4.4B 4.2B 4.3B 4.6B
Operating Income
470M 420M 480M 670M 660M
Other Income Expense Net
0 0 0 41M 0
EBIT
470M 420M 480M 710M 660M
Interest Income
130M 120M 130M 170M 220M
Pretax Income
-150M 170M 290M 280M -4.8B
Income Tax
13M 25M 160M 160M -840M
Minority Interest
0 0 0 0 0
Net Income
-160M 150M 130M 120M -4B
Net Income Basic
-160M 150M 130M 120M -4B
20 ← 16 2020 2019 2018 2017 2016
Current cash
640M 360M 560M 680M 620M
Short term investments
240M 190M 390M 200M 210M
Receivables
1.1B 1.2B 1.1B 1.1B 1.2B
Inventory
1.2B 970M 880M 810M 800M
Other current assets
240M 190M 390M 200M 210M
Current assets
3.1B 2.8B 2.9B 2.8B 2.8B
Long term investments
8.4B 8.5B 8.1B 8.8B 11B
Property plant equipment
1M 900M 830M 830M 870M
Goodwill
0 0 0 0 0
Intangible assets
6.8B 7.1B 6.9B 7.6B 9.9B
Other assets
370M 400M 360M 400M 200M
Total assets
11B 11B 11B 12B 14B
Accounts payable
540M 520M 470M 450M 470M
Current long term debt
38M 3.4M 190M 70M 570M
Other current liabilities
800M 810M 870M 920M 790M
Total current liabilities
1.4B 1.3B 1.5B 1.4B 1.8B
Long term debt
3.5B 3.4B 3.1B 3.3B 5.2B
Other liabilities
640M 520M 440M 430M 460M
Minority Interest
0 300K 100K 100K -500K
Total Liabilities
5.8B 5.5B 5.3B 5.5B 7.9B
Common stock
140M 140M 140M 140M 140M
Retained earning
-1.9B -1.7B -1.8B -2B -2.1B
Treasury stock
0 0 0 0 0
Capital surplus
Shareholder equity
5.7B 5.8B 5.7B 6.2B 6B
Net tangible assets
-1.1B -1.3B -1.2B -1.4B -4B
20 ← 16 2020 2019 2018 2017 2016
Net Income
-160M 150M 130M 120M -4B
Depreciation
380M 400M 420M 440M 460M
Changes in receivables
-190M 170M -58M -45M -110M
Changes in inventories
230M 89M 71M 12M -44M
Cash change
280M -200M -120M 56M -180M
Cash flow
640M 390M 590M 700M 650M
Capital expenditures
-170M -140M -100M -89M -110M
Investments
Investing activity other
Total investing cash flows
-190M -600M -130M 2.3B -180M
Dividends paid
120M
Net borrowings
2.7B 2.8B 2.3B 2.5B 5B
Other financing cash flows
Cash flow financing
-180M 1.8M -570M -3B -270M
Exchange rate effect